Promoters held 53.96 per cent stake in the company as of 30-Sep-2022, while FIIs owned 8.85 per cent, DIIs 18.47 per cent.

Stock has broken out of a month long consolidation, making a base at 2,000 levels

J B Chemicals & Pharmaceuticals, incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 15726.17 Crore) operating in Pharmaceuticals sector.

The company has slashed the price of Azmarda (Saccubutril-Valsartan), 50 mg, to Rs 39.6 per tablet as against Rs 78 per tablet earlier

Prabhudas Lilladher is bullish on J.B. Chemicals and Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2350 in its research report dated November 15, 2022.

Prabhudas Lilladher is bullish on J.B. Chemicals and Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1950 in its research report dated July 19, 2022.

J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 12820.33 Crore) operating in Pharmaceuticals sector.

The deals are valued at around Rs 1.31 lakh per sq ft, making them one of the costliest property transactions in the country. Stamp duty alone for these transactions is around Rs 7 crore. While Mody, who is part of promoters group and former President of the company, has bought the apartment spread over 5,341 sq ft on the 5th floor for Rs 70 crore, his sister Asher has purchased the 5,284-sq-ft apartment on the 4th floor for Rs 68 crore.

On the occasion of 'World No Tobacco Day', the drug maker has also launched an Artificial Intelligence-enabled chatbot 'Dr Will', which would encourage and support tobacco smokers to quit smoking.